Cellular and humoral changes after splenectomy

Abstract

The work is devoted to the human immune system and state of immunity in patients after gastrectomy with splenectomy for gastric cancer. The gold standard of gastric cancer treatment is the surgical method with the use of extended lymphodissection D2. Often with proximal and total involvement of stomach, the removed block includes the spleen for better radicality. In the world literature, however, no common view of the necessity of splenectomy exists as later such patients develop immunodeficiency which can further lead to different postoperative complications negatively affecting survival. There are few studies of immunological changes of patients with gastric cancer after gastrosplenectomy with extended lymphodissection D2. Immunological changes are poorly studied in different stages of patient management after such operative interventions: before the operation and at various stages after it. The article gives a brief analysis of the anatomical and physiological structure of the spleen - one of the important organs of the reticuloendothelial system. Great attention is paid to immunocompetent cells. The most important clinical studies on the subpopulations of cells and humoral factors of antiviral and antimicrobial mechanisms of protection in a healthy organism and in patients with OPSI-syndrome are analyzed in detail. The review presents the data on the influence of splenectomy in gastrectomy for gastric cancer on the development of postoperative complications as well as methods of treatment of complications associated with splenectomy, the use of immunostimulants, autolienotransplantation, methods of ligation of the splenic artery, and spleen-preserving lymphodissection.

Keywords

spleen / immunity / immunocompetent cells / gastric cancer / gastrosplenectomy / lymphodissection / autolienotransplantation

References

[1] Sapin M.R., Etingen L.E. The human immune system. Meditsina. 1996; 302 p. (In Russ.)

[2] Сапин М.Р., Этинген Л.Е. Иммунная система человека. Медицина. 1996; 302 с.

[3] Abbas A.K., Lichtman A.H., Pober J.S. Cellular and molecular Immunology. W.B. Saunders company. 1996; 28–32.

[4] Abbas A.K., Lichtman A.H., Pober J.S. Cellular and molecular Immunology. W.B. Saunders company. 1996; 28-32.

[5] Kim M., McConnell F., Gaspal F. et al. Function of CD4+, CD3+-cell in relation to B- and T-zone stroma in spleen. Blood. 2007; 109 (4). 1602–1610. DOI: 10.1182/blood-2006-04-018465.

[6] Kim M., McConnell F., Gaspal F. et al. Function of CD4+, CD3+-cell in relation to B- and T-zone stroma in spleen. Blood. 2007; 109 (4). 1602-1610. DOI: 10.1182/blood-2006-04-018465.

[7] Mebius R., Kraal G. Structure and function of the spleen. Nat. Rev. Immunol. 2005; 5: 606–616. DOI: 10.1038/nri1669.

[8] Mebius R., Kraal G. Structure and function of the spleen. Nat. Rev. Immunol. 2005; 5: 606-616. DOI: 10.1038/nri1669.

[9] O’Neill H.C., Wilson H., Quah B. et al. Dendritic cell development in long-term spleen stromal cultures. Stem Cell. 2004; 22 (4). 475–486. DOI: 10.1634/stemcells.22-4-475.

[10] O’Neill H.C., Wilson H., Quah B. et al. Dendritic cell development in long-term spleen stromal cultures. Stem Cell. 2004; 22 (4). 475-486. DOI: 10.1634/stemcells.22-4-475.

[11] Crowley M., Reilly C., Lo D. Influence of lympho­cytes on the presence and organization of dendritic cell sub­sets in the spleen. J. Immunol. 1999; 163 (9): 4894–4900. PMID: 10528191.

[12] Crowley M., Reilly C., Lo D. Influence of lymphocytes on the presence and organization of dendritic cell subsets in the spleen. J. Immunol. 1999; 163 (9): 4894-4900. PMID: 10528191.

[13] Briard D., Brouty-Boye D., Azzarone B. Fibroblasts from human spleen regulate NK cell differentiation from blood CD34+ progenitors via cell surface II-15. J. Immunol. 2002; 168 (9). 4326–4332. DOI: 10.4049/jimmunol.168.9.4326.

[14] Briard D., Brouty-Boye D., Azzarone B. Fibroblasts from human spleen regulate NK cell differentiation from blood CD34+ progenitors via cell surface II-15. J. Immunol. 2002; 168 (9). 4326-4332. DOI: 10.4049/jimmunol.168.9.4326.

[15] Galibin O.V., Belyaeva I.G., Doil’nitsyna O.V. Surgical correction of post-splenectomy syndrome. Tsitologiya. 2001; 43 (4). 332. (In Russ.)

[16] Галибин О.В., Беляева И.Г., Доильницына О.В. Хирургическая коррекция постспленэктомического синдрома. Цитология. 2001; 43 (4): 332.

[17] Cyster J.C., Goodnow C.C. Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity. 1995; 3 (6). 691–701. DOI: 10.1016/1074-7613(95)90059-4.

[18] Cyster J.C., Goodnow C.C. Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity. 1995; 3 (6). 691-701. DOI: 10.1016/1074-7613(95)90059-4.

[19] Mebius R.E., Kraal G. Structure and function of the spleen. Nat. Rev. Immunol. 2005; 5 (8): 606–616. DOI: 10.1038/nri1669.

[20] Mebius R.E., Kraal G. Structure and function of the spleen. Nat. Rev. Immunol. 2005; 5 (8): 606-616. DOI: 10.1038/nri1669.

[21] Timens W., Leemans R. Splenic autotransplantation and the immune system. Adequate testing required for evaluation of effect. Ann. Surg. 1992; 215 (3): 256–260. DOI: 10.1097/00000658-199203000-00010.

[22] Timens W., Leemans R. Splenic autotransplantation and the immune system. Adequate testing required for evaluation of effect. Ann. Surg. 1992; 215 (3): 256-260. DOI: 10.1097/00000658-199203000-00010.

[23] Pabst R. The spleen in lymphocyte migration. Immunol. Today. 1988; 9 (2): 43–45. DOI: 10.1016/0167-5699(88)91258-3.

[24] Pabst R. The spleen in lymphocyte migration. Immunol. Today. 1988; 9 (2): 43-45. DOI: 10.1016/0167-5699(88)91258-3.

[25] Maslyakov V.V., Kirichuk V.F., Chumanov A.Yu. Changes in the immune status in the immediate postoperative period in patients operated for spleen injury. Novosti khirurgii. 2011; 19 (1): 32–36. (In Russ.)

[26] Масляков В.В., Киричук В.Ф., Чуманов А.Ю. Изменения иммунного статуса в ближайшем послеоперационном периоде у пациентов, оперированных при травме селезенки. Новости хирургии. 2011; 19 (1): 32-36.

[27] Brady M.S., Rogatko A., Dent L.L. et al. Effect of Splenectomy on Morbidity and Survival Following Curative Gastrectomy for Carcinoma. Arch. Surg. 1991; 126 (3): 359–364. DOI: 10.1001/archsurg.1991.01410270105017.

[28] Brady M.S., Rogatko A., Dent L.L. et al. Effect of Splenectomy on Morbidity and Survival Following Curative Gastrectomy for Carcinoma. Arch. Surg. 1991; 126 (3): 359-364. DOI: 10.1001/archsurg.1991.01410270105017.

[29] Okuno K., Tanaka A., Shigeoka H. et al. Supression of T-cell function in gastric cancer patients after total gastrectomy with splenectomy: implications of splenic autotransplantation. Gastric Cancer. 1999; 2 (1): 20–25. DOI: 10.1007/s101200050016.

[30] Okuno K., Tanaka A., Shigeoka H. et al. Supression of T-cell function in gastric cancer patients after total gastrectomy with splenectomy: implications of splenic autotransplantation. Gastric Cancer. 1999; 2 (1): 20-25. DOI: 10.1007/s101200050016.

[31] Pavlova I., Bubnova L., Orlov M. et al. The influence of splenectomy on cell and humoral immunity: distant results. Human Immunology. 2000; 61 (1): 146.

[32] Balsalobre B., Carbonell-Tatay F. Cellular immunity in splenectomized patients. J. Investig. Allergol. Clin. Immunol. 1991; 1 (4): 235–238. PMID: 1669582.

[33] Balsalobre B., Carbonell-Tatay F. Cellular immunity in splenectomized patients. J. Investig. Allergol. Clin. Immunol. 1991; 1 (4): 235-238. PMID: 1669582.

[34] Karakantza M., Theodorou Gl., Mouzaki A. et al. In vitro study of the long-term effects of post-traumatic splenectomy on cellular immunity. Scand. J. Immunol. 2004; 59 (2): 209–219. DOI: 10.1111/j.0300-9475.2004.01379.x.

[35] Karakantza M., Theodorou Gl., Mouzaki A. et al. In vitro study of the long-term effects of post-traumatic splenectomy on cellular immunity. Scand. J. Immunol. 2004; 59 (2): 209-219. DOI: 10.1111/j.0300-9475.2004.01379.x.

[36] Passlick B., Izbicki J.R., Wadhas C. et al. Posttraumatic splenectomy does not influence human ­peripheral blood mononuclear cell subsets. J. Clin. Lab. Immunol. 1991; 34 (4): 157–161. PMID: 1668282.

[37] Passlick B., Izbicki J.R., Wadhas C. et al. Posttraumatic splenectomy does not influence human peripheral blood mononuclear cell subsets. J. Clin. Lab. Immunol. 1991; 34 (4): 157-161. PMID: 1668282.

[38] Hansen K., D. Singer. Asplenic-hyposplenic overwhelming sepsis: postsplenectony sepsis revisited. ­Pediatr. Dev. Pathol. 2001; 4 (2): 105–121. DOI: 10.1007/s100240010145.

[39] Hansen K., D. Singer. Asplenic-hyposplenic overwhelming sepsis: postsplenectony sepsis revisited. Pediatr. Dev. Pathol. 2001; 4 (2): 105-121. DOI: 10.1007/s100240010145.

[40] Brandlein S., Lorenz J., Ruoff N. et al. Human monoclonal IgM antibodies with apoptotic activity isolated from cancer patients. Hum. antibodies. 2002; 11 (4): 107–119. DOI: 10.3233/HAB-2002-11401.

[41] Brandlein S., Lorenz J., Ruoff N. et al. Human monoclonal IgM antibodies with apoptotic activity isolated from cancer patients. Hum. antibodies. 2002; 11 (4): 107-119. DOI: 10.3233/HAB-2002-11401.

[42] Di Sabatino A., Rosado M., Ciccocioppo R. et al. Depletion of immunoglobulin M memory B cells is associated with splenic hypofunction in inflammatory bowel disease. Am. J. Gastroenterology. 2005; 100 (8): 1788–1795. DOI: 10.1111/j.1572-0241.2005.41939.x.

[43] Di Sabatino A., Rosado M., Ciccocioppo R. et al. Depletion of immunoglobulin M memory B cells is associated with splenic hypofunction in inflammatory bowel disease. Am. J. Gastroenterology. 2005; 100 (8): 1788-1795. DOI: 10.1111/j.1572-0241.2005.41939.x.

[44] Maruyama K., Okabayashi K., Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World Journal of Surgery. 1987; 11 (4): 418–425. DOI: 10.1007/BF01655804.

[45] Maruyama K., Okabayashi K., Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World Journal of Surgery. 1987; 11 (4): 418-425. DOI: 10.1007/BF01655804.

[46] Otsuji E., Yamagushi T., Sawai K. et al. End results of simultaneous pancreatectomy, splenectomy and total gastrectomy for patients with gastric carcinoma. Br. J. Cancer. 1997; 75 (11–12): 1219–1223. DOI: 10.1038/sj.bjc.6690285.

[47] Otsuji E., Yamagushi T., Sawai K. et al. End results of simultaneous pancreatectomy, splenectomy and total gastrectomy for patients with gastric carcinoma. Br. J. Cancer. 1997; 75 (11-12): 1219-1223. DOI: 10.1038/sj.bjc.6690285.

[48] Akhmetzyanov F.Sh., Ruvinskiy D.M., Akhmetzyanova F.F., Kaulgud Kh.A. Splenectomy in the surgical treatment of gastric cancer. Povolzhskiy oncologicheskiy vestnik. 2014; 2: 9–26. (In Russ.)

[49] Ахметзянов Ф.Ш., Рувинский Д.М., Ахметзянова Ф.Ф., Каулгуд Х.А. Спленэктомия в хирургическом лечении рака желудка. Поволжский онкологический вестник. 2014; 2: 9-26.

[50] Turkin I.N., Davydov M.M., Davydov M.I. Does splenectomy affect the incidence of pancreatic complications in stomach cancer? Vestnik RONTs im. N.N. Blohina RAMN. 2013; 24 (1): 31–34. (In Russ.)

[51] Туркин И.Н., Давыдов М.М., Давыдов М.И. Влияет ли спленэктомия при раке желудка на частоту развития панкреатогенных осложнений? Вестник РОНЦ им. Н.Н. Блохина РАМН. 2013; 24 (1): 31-34.

[52] Brady M.S., Rogatko A., Dent L.L., Shiu M.H. Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma. Arch. surgery. 1991; 126 (3): 359–364. DOI: 10.1001/archsurg.1991.01410270105017.

[53] Brady M.S., Rogatko A., Dent L.L., Shiu M.H. Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma. Arch. surgery. 1991; 126 (3): 359-364. DOI: 10.1001/archsurg.1991.01410270105017.

[54] Bonekamp J.J., Shongun I., Welvaart K. et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995; 345 (8952): 745–748. DOI: 10.1016/S0140-6736(95)90637-1.

[55] Bonekamp J.J., Shongun I., Welvaart K. et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995; 345 (8952): 745-748. DOI: 10.1016/S0140-6736(95)90637-1.

[56] Wanebo H.J., Kennedy B.J., Winchester D.P. et al. Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on longterm survival. J. Am. Coll. Surg. 1997; 185 (2): 177–184. DOI: 10.1016/S1072-7515(01)00901-2.

[57] Wanebo H.J., Kennedy B.J., Winchester D.P. et al. Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on longterm survival. J. Am. Coll. Surg. 1997; 185 (2): 177-184. DOI: 10.1016/S1072-7515(01)00901-2.

[58] Cuschieri A., Weeden S., Fielding J. et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Br. J. Cancer. 1999; 79 (9–10): 1522–1530. DOI: 10.1038/sj.bjc.6690243.

[59] Cuschieri A., Weeden S., Fielding J. et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Br. J. Cancer. 1999; 79 (9-10): 1522-1530. DOI: 10.1038/sj.bjc.6690243.

[60] Gladinets M.M., Sadykov A.K., Maratova A.T. et al. Surgical tactics for spleen injuries. Nauka i zdravookhranenie. 2013; 1: 16–17. (In Russ.)

[61] Гладинец М.М., Садыков А.К., Маратова А.Т. и др. Хирургическая тактика при повреждениях селезенки. Наука и здравоохранение. 2013; 1: 16-17.

[62] Seufert R.M. Autotransplantation of the spleen. Langenbecks Archiv für Chirurgie. 1986; 369 (1): 393–397. DOI: 10.1007/BF01274397.

[63] Seufert R.M. Autotransplantation of the spleen. Langenbecks Archiv für Chirurgie. 1986; 369 (1): 393-397. DOI: 10.1007/BF01274397.

[64] Apartsin K.A., Panasyuk A.I., Grigor’ev E.G. Complications of autotransplantation of the spleen tissue. Sibirskiy meditsinskiy zhurnal. 1995; 1 (1): 10–13. (In Russ.)

[65] Апарцин К.А., Панасюк А.И., Григорьев Е.Г. Осложнения аутотрансплантации ткани селезенки. Сибирский медицинский журнал. 1995; 1 (1): 10-13.

[66] Stilidi I.S., Nered S.N., Glukhov E.V. Spleen-preserving D2 lymphodissection in the surgery of the cancer of body and the proximal part of the stomach. Annaly khirurgii. 2012; 1: 52–57. (In Russ.)

[67] Стилиди И.С., Неред С.Н., Глухов Е.В. Спленосохранная D2 лимфодиссекция в хирургии рака тела и проксимального отдела желудка. Анналы хирургии. 2012; 1: 52-57.

[68] Schwarz R.E. Spleen-preserving splenic hilar lymphadenectomy at the time of gastrectomy for cancer: technical feasibility and early results. J. Surg. Oncol. 2002; 79 (1): 73–76. DOI: 10.1002/jso.10036.

[69] Schwarz R.E. Spleen-preserving splenic hilar lymphadenectomy at the time of gastrectomy for cancer: technical feasibility and early results. J. Surg. Oncol. 2002; 79 (1): 73-76. DOI: 10.1002/jso.10036.

[70] Dzhuraev M.D., Umarova A.T., Mirzaraimova S.S. et al. The effect of principled splenectomy on the result of the extended gastrectomy. Sibirskiy onkologicheskiy zhurnal. 2009; (2): 60–63. (In Russ.)

[71] Джураев М.Д., Умарова А.Т., Мирзараимова С.С. и др. Влияние принципиальной спленэктомии на результаты расширенной гастрэктомии. Сибирский онкологический журнал. 2009; (2): 60-63.

[72] Maslyakov V.V., Gromov M.S., Kiri­chuk V.F. et al. Method of correction of immunological complications after splenectomy. Fundamental’nye issledovaniya. 2012; 5 (1): 80–85. (In Russ.)

[73] Масляков В.В., Громов М.С., Киричук В.Ф. и др. Способ коррекции иммунологических осложнений после спленэктомии. Фундаментальные исследования. 2012; 5 (1): 80-85.

[74] Berdov B.A., Skoropad V.Yu., Pakhomenko K.V., Khicheva G.A. Combined treatment of stomach cancer with preoperative and intraoperative radiotherapy. Prakticheskaya onkologiya. 2001; 3 (7): 35–43. (In Russ.)

[75] Бердов Б.А., Скоропад В.Ю., Пахоменко К.В., Хичева Г.А. Комбинированное лечение рака желудка с предоперационным и интраоперационным облучением. Практическая онкология. 2001; 3 (7): 35-43.

[76] Davies J.M., Lewis M.P., Wimperis J. et al. Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: Prepared on behalf of the British Committee for Standards in Haematology by a Working Party of the Haemato-Oncology Task Force. Br. J. Haemotol. 2011; 155 (3): 308–317. DOI: 10.1111/j.1365-2141.2011.08843.x.

[77] Davies J.M., Lewis M.P., Wimperis J. et al. Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: Prepared on behalf of the British Committee for Standards in Haematology by a Working Party of the Haemato-Oncology Task Force. Br. J. Haemotol. 2011; 155 (3): 308-317. DOI: 10.1111/j.1365-2141.2011.08843.x.

[78] Davydov M.I., Turkin I.N., Davydov M.M. Entsiklopedia khirurgii raka zheludka. (Encyclopedia of surgery of stomach cancer.) Moscow: EKSMO Publ. 2011; 536 p. (In Russ.)

[79] Давыдов М.И., Туркин И.Н., Давыдов М.М. Энциклопедия хирургии рака желудка. М.: Изд-во ЭКСМО. 2011; 536 с.

RIGHTS & PERMISSIONS

Akhmetzyanov F.S., Gaynanshin R.R.